Preventing brain metastases in patients with HER2 or triple negative breast cancer

18:34 EDT 3 Jun 2019 | ecancermedicalscience

Dr Alexandra Zimmer speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about ongoing clinical trials looking into the prevention and treatment of brain metastases for patients with HER2 or triple negative breast...

More From BioPortfolio on "Preventing brain metastases in patients with HER2 or triple negative breast cancer"